Search

Your search keyword '"Algharib SA"' showing total 16 results

Search Constraints

Start Over You searched for: Author "Algharib SA" Remove constraint Author: "Algharib SA" Search Limiters Full Text Remove constraint Search Limiters: Full Text
16 results on '"Algharib SA"'

Search Results

1. Antioxidant and renal protective effects of Nano-selenium on adenine-induced acute renal failure in canines.

2. Antibiofilm activity of polyethylene glycol-quercetin nanoparticles-loaded gelatin-N,O-carboxymethyl chitosan composite nanogels against Staphylococcus epidermidis .

3. Basic concepts, recent advances, and future perspectives in the diagnosis of bovine mastitis.

4. Brucellae as resilient intracellular pathogens: epidemiology, host-pathogen interaction, recent genomics and proteomics approaches, and future perspectives.

5. Recent progress of emitting long-wavelength carbon dots and their merits for visualization tracking, target delivery and theranostics.

6. Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide-Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine.

7. Antibacterial activity of florfenicol composite nanogels against Staphylococcus aureus small colony variants.

9. Dietary Parsley Seed Mitigates Methomyl-Induced Impaired Growth Performance, Hemato-Immune Suppression, Oxidative Stress, Hepato-Renal Damage, and Pseudomonas aeruginosa Susceptibility in Oreochromis niloticus .

10. Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives.

11. Antibacterial activity of enrofloxacin loaded gelatin-sodium alginate composite nanogels against intracellular Staphylococcus aureus small colony variants.

12. Enhanced antibacterial activity of tilmicosin against Staphylococcus aureus small colony variants by chitosan oligosaccharide-sodium carboxymethyl cellulose composite nanogels.

13. Apply a Physiologically Based Pharmacokinetic Model to Promote the Development of Enrofloxacin Granules: Predict Withdrawal Interval and Toxicity Dose.

14. Application of a Physiologically Based Pharmacokinetic Model to Develop a Veterinary Amorphous Enrofloxacin Solid Dispersion.

15. Nanoparticles for treatment of bovine Staphylococcus aureus mastitis.

16. Solid Lipid Nanoparticles for Duodenum Targeted Oral Delivery of Tilmicosin.

Catalog

Books, media, physical & digital resources